Research

Cannabis smokers inhale 'significantly' less harmful chemicals than tobacco smokers, but are still not without some risk

Industry advocates praised recommendations to streamline clinical trails and free up the natural health products sector

One hour of nitrous oxide treatment led to weeks-long relief

According to Veterans Affairs Canada, a record number of nearly 16,000 clients were paid back for medical weed

Sharing environment, social and governance data, these reports have gained significant importance in the eyes of Canadian investors

After years of cannabis study at the university, researchers now have dedicated infrastructure and organization

After drinking the psychedelic plant brew together, Jewish-Israeli and Arab-Palestinian participants reported moments of deep connection, unity and oneness

Toronto-based Field Trip launched two new polls that show more people are open to using psychedelics to treat rising pandemic-related mental health issues

With only one approved US university supplying low-quality cannabis for decades, the DEA says it will finally open up licensing

Australis Capital CSO Jason Dyck explains how each type of cannabis is a distinct set of compounds and how zebrafish are contributing to pain research

As active client registrations drop 15%, it's time to remove barriers like taxes in Canada's medical cannabis program, says a leading expert and advocate

Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA

Aside from impairment testing, Ontario-based Zentrela wants to work with cannabis producers to generate accurate product claims

Monthly cannabis sales dipped slightly in the shortest month of the year, but daily purchases were up 4%

Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy

Identifying specific terpene-cannabinoid combinations can create new ways to improve medical therapy, researchers suggest

Despite ongoing Covid-19 restrictions, data firms and cannabis companies report record sales on the stoner holiday

More alcohol, but not weed, use during youth is associated with thinning in parts of the brain associated with intelligence, impulsivity and risky behaviour

The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine

The resource-rich country produces less emissions than the US, but it's still a big problem that government isn't tracking and firms don't want to talk about

Canadian provinces are slowly easing strict marketing rules to be on par with alcohol and meet broader public policy goals, U of A prof says

Better data would allow researchers to test the effectiveness of regulations and lead to a more robust market overall, experts say

It's essential to test products pre-launch as they can create bad consumer experiences, says Nextleaf Solutions, which just got approved for human trials

Ontario led all provinces in Q4 with $251 million in legal weed sales, according to the OCS's latest quarterly report

Coming of legal age by the day, cannabis's fastest growing consumer demographic is motivated by identity formation, experts say

Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off

A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy

Despite new lockdown orders issued in some provinces, recreational weed sales climbed 14.3% in December to $298.4M

Pricing depends on various factors including competition, a spokesperson says, who confirmed no customer data was leaked

Maine-based Desert Harvest is working with university researchers to see if its CBD-aloe vera formula can treat pain more safely and effectively than opioids

While initial research suggests CBD is well-tolerated in pups, even Canopy recommends consulting your vet before starting any cannabis treatment

Led by robust medical markets in Israel and Germany, 13,849 kg of dried flower and 10,494 L of oil was shipped out of country

In the first substitution study to track individual use over time, researchers found stark drops in use of opioids and other medications

With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field

From CBD drivers to stoner rats, legal reform continues to push weed research to an all-time high

Brock University's Michael Armstrong argues Canada's restrictive labelling rules incentivize producers to maximize THC content and minimize price

Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine

A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound

Lead researcher and Tilray VP Philippe Lucas says new data shows why Canada regulating weed on par with alcohol would reduce societal harms

A recent questionnaire highlights how a taxed system with strictly commercial access leaves patients treating themselves outside official channels